Tri Wibawa

Tri Wibawa is a medical and health science expert whose research interests include antimicrobial resistance, drug and vaccine development, infectious disease genetic susceptibility, and vaccine development. He received his MD from Universitas Gadjah Mada and his Ph.D. in Molecular Medicine from Kobe University in Japan. Years later, he returned to Gadjah Mada Universitas to pursue a master’s degree in Clinical Microbiology. Tri Wibawa is currently a professor in the Department of Microbiology, Faculty of Medicine, Public Health, and Nursing at Universitas Gadjah Mada. He is currently the chairman of three committees, one of which is the Faculty of Medicine Universitas Gadjah Mada’s Ethical Committee (research).

Latest publications

• The diversity and susceptibility against antibiotics of Salmonella spp. clinical isolates from Yogyakarta, Indonesia (2022)
• Modified Non-Cultured Cell Spray Induced Epithelization in LAMB3 Mutation Epidermolysis Bullosa (2022)
• “We face the same risk as the other health workers”: Perceptions and experiences of community pharmacists in Indonesia during the COVID-19 pandemic (2022)